Top Markets
Coin of the day
Hemostemix Inc. Hemostemix Inc.

Hemostemix Inc.

HEM
Ранг среди акций #32158
Hemostemix Inc., a clinical stage biotechnology company, develops,... Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Цена акции
$0.05504527
Последняя синхронизация: 2026-08-17
Рыночная капитализация
$10.89M
Изменение (1 день)
15.38%
Изменение (1 год)
-10.64%
Страна
CA
Торговля Hemostemix Inc. (HEM)

Категория

История цены акций Hemostemix Inc. (HEM)
Наивысшая цена закрытия: $0.05 2026-08-01

Наименьшая цена закрытия: $13.17 2014-11-01
История цены акций Hemostemix Inc. с 2014 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -3.76%
2025 16.47%
2024 0.85%
2023 -52.75%
2022 -7.37%
2021 -60.16%
2020 105.00%
2019 -89.61%
2018 12.43%
2017 -27.92%
2016 -79.94%
2015 -39.73%
2014 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$515.58 32.24%
US
$992.01 50.00%
NL
$110.53 -37.27%
AU
$736.64 6.99%
CH
$1.06K -6.67%
KR